Skip to main content

Table 1 Patient profiles and characteristics

From: Decreased effector memory CD45RA+ CD62L- CD8+ T cells and increased central memory CD45RA- CD62L+ CD8+ T cells in peripheral blood of rheumatoid arthritis patients

Patient number/sex/age (years)

Disease duration (years)

Therapy

X-ray findings

Patients with rheumatoid arthritis

   1/F/56

1

MTX, steroids

None

   2/F/53

5

MTX, Inf, steroids

Erosions

   3/F/46

4

MTX

Erosions

   4/F/33

3

Hcq, MTX

Erosions

   5/M/63

3

Lef

Erosions, osteopenia

   6/F/52

2

Lef, steroids

Erosions

   7/F/40

6

Etanercept

Erosions

   8/F/50

6

Lef

Erosions

Patients with systemic lupus erythematosus

   11/F/68

1

Hcq, steroids

None

   12/F/46

5

Hcq

None

   13/F/25

5

Hcq

None

   14/F/47

9

Hcq, MTX

None

   15/F/22

5

Hcq, steroids

Jaccoud's arthropathy

   16/F/38

6

Hcq, steroids

None

   17/F/46

4

Hcq, steroids

None

   18/F/55

10

Hcq, steroids

None

   19/F/45

3

Hcq, steroids

None

   20/F/61

18

Hcq

None

   21/F/35

5

Hcq, MTX, steroids

None

   22/F/53

8

Hcq

None

  1. F, female; Hcq, hydroxychloroquine; Inf, infliximab; Lef, leflunomide; M, male; MTX, methotrexate.